Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Spratt

Showing results (291-300 of 498) with videos related to

Pageof 50
Sort By:
JCO Precision Oncology|August 25, 2020
Circulating Tumor Cells as a Predictor of Treatment Response in Clinically Localized Prostate CancerSimpa S Salami, Udit Singhal, Daniel E Spratt, et al.
EJNMMI Research|January 24, 2016
Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modelingEdward K Fung, Sarah M Cheal, Shoaib B Fareedy, et al.
European Urology|March 9, 2023
Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 TrialSoumyajit Roy, Yilun Sun, Scott C Morgan, et al.
European Urology|May 27, 2019
The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus StatementMatthew R Cooperberg, Peter R Carroll, Marc A Dall'Era, et al.
JNCI Cancer Spectrum|October 5, 2023
Individual-level home values and cancer mortality in a statewide registryAlec Zhu, Stephen Rhodes, Weichuan Dong, et al.
International Journal of Radiation Oncology, Biology, Physics|December 4, 2020
Factors Influencing Noncompletion of Radiation Therapy Among Men With Localized Prostate CancerEdward Christopher Dee, Vinayak Muralidhar, Melaku A Arega, et al.
International Journal of Cancer|July 21, 2021
Pan-cancer analysis of prognostic metastatic phenotypesNicholas G Zaorsky, Xi Wang, Sara M Garrett, et al.
NEJM Evidence|October 28, 2025
Age and Treatment Intensification in Metastatic Hormone-Sensitive Prostate CancerAlicia K Morgans, Soumyajit Roy, Angela Y Jia, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2023
Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADARWee Loon Ong, John Nikitas, David Joseph, et al.
Journal of the National Cancer Institute|July 22, 2021
Cancer Misinformation and Harmful Information on Facebook and Other Social Media: A Brief ReportSkyler B Johnson, Matthew Parsons, Tanya Dorff, et al.
Pageof 50

Showing results (291-300 of 498) with videos related to

Sort By:
Pageof 50
JCO Precision Oncology|August 25, 2020
Circulating Tumor Cells as a Predictor of Treatment Response in Clinically Localized Prostate CancerSimpa S Salami, Udit Singhal, Daniel E Spratt, et al.
EJNMMI Research|January 24, 2016
Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modelingEdward K Fung, Sarah M Cheal, Shoaib B Fareedy, et al.
European Urology|March 9, 2023
Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 TrialSoumyajit Roy, Yilun Sun, Scott C Morgan, et al.
European Urology|May 27, 2019
The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus StatementMatthew R Cooperberg, Peter R Carroll, Marc A Dall'Era, et al.
JNCI Cancer Spectrum|October 5, 2023
Individual-level home values and cancer mortality in a statewide registryAlec Zhu, Stephen Rhodes, Weichuan Dong, et al.
International Journal of Radiation Oncology, Biology, Physics|December 4, 2020
Factors Influencing Noncompletion of Radiation Therapy Among Men With Localized Prostate CancerEdward Christopher Dee, Vinayak Muralidhar, Melaku A Arega, et al.
International Journal of Cancer|July 21, 2021
Pan-cancer analysis of prognostic metastatic phenotypesNicholas G Zaorsky, Xi Wang, Sara M Garrett, et al.
NEJM Evidence|October 28, 2025
Age and Treatment Intensification in Metastatic Hormone-Sensitive Prostate CancerAlicia K Morgans, Soumyajit Roy, Angela Y Jia, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2023
Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADARWee Loon Ong, John Nikitas, David Joseph, et al.
Journal of the National Cancer Institute|July 22, 2021
Cancer Misinformation and Harmful Information on Facebook and Other Social Media: A Brief ReportSkyler B Johnson, Matthew Parsons, Tanya Dorff, et al.
Pageof 50